# Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study

> **NCT05033743** · PHASE2,PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 24 (actual)

## Conditions studied

- Recurrent Bacterial Vaginosis

## Interventions

- **DRUG:** Secnidazole 2 GM Oral Granules

## Key facts

- **NCT ID:** NCT05033743
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-09
- **Primary completion:** 2022-10-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05033743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05033743, "Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05033743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*